With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

We think its portfolio and pipeline support a wide moat, and with the HCV market stabilizing, Gilead needs strong continued innovation in HIV, solid oncology pipeline data, and smart future ...

On the second floor of The Laurelton, a school-turned-office building in Irondequoit, Rochester Clinical Research, or RCR, studies the effectiveness of various medical ...

In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...

According to the World Health Organization (WHO), over 22% of the global population smokes, with more than 9 million smoking-related deaths reported annually. Effective treatments to alleviate ...

At the inaugural Singapore-New Zealand Judicial Roundtable that took place in Auckland, New Zealand on 7 February 2025, The Honourable the Chief Justice Sundaresh Menon of Singapore led the discussion ...

Given the success of the previous Research Topic 'Exploring Small Molecule Inhibitors in Cardiovascular and Cerebrovascular Diseases', we are pleased to ...

Hena, has been officially inaugurated at San Vinċenz de Paul. This innovative project provides a relaxing space for residents, their families and visitors to unwind and interact with animals. With an ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...

Here is an in-depth look at the inner workings of a luxury hotel property that represents the pinnacle of regenerative ...